BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8437534)

  • 1. [Glucocorticoids in rheumatology].
    Sörensen H
    Med Klin (Munich); 1993 Jan; 88 Suppl 1():13-4. PubMed ID: 8437534
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
    Caplan L; Russell AS; Wolfe F
    J Rheumatol; 2005 Oct; 32(10):1863-5. PubMed ID: 16206335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cortisone therapy of rheumatism].
    Mathies H; Schattenkirchner M
    Internist (Berl); 1967 Mar; 8(3):117-23. PubMed ID: 4295790
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic corticosteroid therapy in rheumatic diseases.
    Fries JF; McDevitt HO
    Ration Drug Ther; 1972 Nov; 6(11):1-5. PubMed ID: 4147211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic therapy with glucocorticoids. Treatment of rheumatic diseases].
    Möller B
    Pharm Unserer Zeit; 2003; 32(4):302-5. PubMed ID: 12899067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of nonsteroidal anti-inflammatory agents. III: Principles of therapeutic use].
    Reinicke C
    Z Arztl Fortbild (Jena); 1985; 79(12):515-22. PubMed ID: 3929483
    [No Abstract]   [Full Text] [Related]  

  • 7. Key developments in rheumatology.
    Panthakalam S; Pal B
    Practitioner; 2000 Dec; 244(1617):1024-6, 1029-32. PubMed ID: 11220170
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucocorticoids in the therapy of rheumatism. 2: Systemic corticoid therapy].
    Kaiser H
    Fortschr Med; 1998 Dec; 116(34):41-3. PubMed ID: 10024761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of evolutive chronic polyarthritis with chrysotherapy. Reports. Conclusions. Summaries].
    Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):669-79. PubMed ID: 5004879
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term therapy with low dosage corticoids in rheumatology is well established].
    Hatz HJ
    MMW Fortschr Med; 1999 Sep; 141(38):58-9. PubMed ID: 10904623
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    Davis JM; Maradit-Kremers H; Gabriel SE
    J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].
    Freier D; Strehl C; Buttgereit F
    Z Rheumatol; 2019 Oct; 78(8):775-788. PubMed ID: 31535201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
    Boers M
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):21-9. PubMed ID: 15123035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bone biology to clinical outcome: state of the art and future perspectives.
    Schett G; Saag KG; Bijlsma JW
    Ann Rheum Dis; 2010 Aug; 69(8):1415-9. PubMed ID: 20650876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of side effects of glucocorticoid therapy in relation to the regimen for administering the hormonal preparations].
    Zaremba EF
    Vrach Delo; 1984 Nov; (11):60-3. PubMed ID: 6396947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should long-term corticosteroid treatment be given in rheumatoid arthritis?].
    Laroche M; Arlet J
    Rev Rhum Ed Fr; 1993 May; 60(5):317-20. PubMed ID: 8167636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].
    Freier D; Strehl C; Buttgereit F
    Hautarzt; 2020 Feb; 71(2):139-153. PubMed ID: 31980858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of 6-alpha-fluoro-16-alpha-methyl-1-dehydro-corticosterone (fluocortolone) in internal diseases].
    Stacher A; Böhnel J; Schindler H; Seifert E
    Arzneimittelforschung; 1968 Mar; 18(3):330-4. PubMed ID: 5303195
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of glucocorticoids in therapy of rheumatic disease. 1: Value--precautions--choice of drug preparation].
    Kaiser H
    Fortschr Med; 1998 Nov; 116(32):44-5. PubMed ID: 9880952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.